How do we age? New insights into aging

Medicover Genetics Editorial Team|

Scientifically checkedView our editorial guidelines
Scientifically checked

A recent study tracked molecular changes in 108 people over time, revealing that aging involves critical shifts around ages 44 and 60. These changes impact immune function and metabolism, shedding light on how aging affects disease risk and highlighting new areas for potential treatments. Read more about this under Article 1 below.

Article 1: Nonlinear dynamics of multi-omics profiles during human aging

This study examines nonlinear molecular changes associated with aging by analysing data from 108 individuals aged 25-75 over several years. Researchers identified key shifts in aging-related markers around ages 44 and 60, linked to changes in immune function, metabolism, and disease risks. These findings suggest that aging-related diseases and biological functions change nonlinearly, providing new insights into the molecular pathways involved and potential therapeutic targets to enhance healthspan. Read the full article .

In summary: Aging reveals molecular shifts around ages 44 and 60

Article 2: Feeding gut microbes to nourish the brain: unravelling the diet–microbiota–gut–brain axis

This review highlights the growing link between diet, gut microbiota, and brain health. Poor dietary habits are linked to rising brain disorders, while healthy diets support mood and cognitive function. The “diet–microbiota–gut–brain axis” is proposed as a key pathway influencing brain health. The review explores how diet affects gut microbiota, impacting cognition and emotional health, and suggests this axis as a potential target for diagnosing and treating neuropsychiatric disorders. Read the full article .

In summary: Diet affects gut microbiota, influencing brain health

Article 3: ONCOLINER: A new solution for monitoring, improving, and harmonising somatic variant calling across genomic oncology centres

This study introduces ONCOLINER, a tool designed to improve and standardise tumour genome analysis across cancer research centres and hospitals. By enhancing the identification of somatic variants like SNVs, indels, and structural variants, ONCOLINER helps ensure more consistent tumour diagnoses and facilitates data sharing. It provides personalised recommendations for harmonising genomic analysis, supporting more reliable cancer research and personalised medicine in clinical oncology. Read the full article .

In summary: ONCOLINER enhances tumour genome analysis and diagnosis consistency

Article 4: Genetic associations between non-cognitive skills and academic achievement over development

This study explored the relationship between non-cognitive skills (like motivation and self-regulation) and academic achievement in over 10,000 children aged 7 to 16 in England and Wales. The findings showed that non-cognitive skills increasingly influenced academic success as children grew older. Genetic analyses revealed that the connection between non-cognitive traits and academic performance strengthened over time, suggesting a possible role for gene-environment interactions in shaping academic development. Read the full article .

In summary: Non-cognitive skills and genetics increasingly affect academic success

Stay informed on the latest monkeypox developments: The WHO has declared a public health emergency as a new strain of the mpox virus (clade Ib) spreads in Africa. Unlike earlier strains, clade Ib is transmitted mainly through human contact, including sexual transmission, leading to 18,000 suspected cases and 600 deaths in the Democratic Republic of the Congo. Existing vaccines, designed for a different strain, may be less effective against clade Ib, complicating outbreak control. Learn more

Last updated: 11.09.2026

Latest articles

All about genetics
Health and well-being
Hereditary diseases
  • VERACITY

    New-generation non-invasive prenatal screening from week 9 of pregnancy, analysing fetal cell-free DNA in maternal blood to detect selected chromosomal abnormalities with high sensitivity and specificity for early and reliable prenatal risk assessment.

  • Pharmacogenomics

    Enabling personalised treatments for safer, more effective care through genetic insights that guide optimal prescribing from the start and refine therapy when patients experience side effects or poor response.

  • ebiom+

    A comprehensive assessment of the endometrial microbiome and chronic endometritis pathogens to enhance clinical outcomes, prevent treatment delays, and support a more informed, personalised fertility care.

  • WES

    Advanced sequencing that simultaneously analyses a broad range of genes to detect the genetic basis of complex diseases, improve diagnostic accuracy, and inform recurrence risk assessment for better clinical decision-making.

Why Medicover Genetics

Leader in genetic testing with >25 years of experience in counselling and diagnostics

Comprehensive CE-IVD kit portfolio and seamless Technology Transfer solution for laboratories of any size

End-to-end clinical workflow from sample processing to sequencing analysis and reporting

CAP- accredited, GMP- and ISO9001, 15189 and 13485 certified

Are you a patient?

Are you a physician?